🔗 Share this article

This year's prestigious award in medical science has been awarded for transformative findings that clarify how the body's defense network targets dangerous infections while protecting the healthy tissues.

A trio of esteemed scientists—Japan's Prof. Sakaguchi and American scientists Mary Brunkow and Fred Ramsdell—received this honor.

The work uncovered unique "security guards" within the immune system that eliminate malfunctioning immune cells that could harming the body.

The discoveries are now enabling new treatments for immune disorders and malignancies.

The winners will divide a prize fund valued at 11m Swedish kronor.

Crucial Findings

"Their research has been decisive for comprehending how the body's defenses functions and why we don't all suffer from severe autoimmune diseases," stated the chair of the Nobel Committee.

This trio's studies explain a fundamental question: How does the immune system defend us from numerous invaders while keeping our own tissues intact?

Our immune system employs white blood cells that scan for indicators of disease, even pathogens and bacteria it has not met before.

These defenders utilize detectors—called recognition units—that are generated randomly in a vast number of variations.

This gives the immune system the capacity to combat a broad range of invaders, but the randomness of the mechanism unavoidably produces white blood cells that can attack the host.

Protectors of the Immune System

Researchers previously knew that some of these harmful defense cells were eliminated in the thymus—the site where white blood cells develop.

This year's award honors the identification of regulatory T-cells—described as the immune system's "security guards"—which travel through the body to neutralize any immune cells that assault the healthy cells.

We know that this mechanism malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel added, "The discoveries have laid the foundation for a novel area of investigation and spurred the creation of new treatments, for example for cancer and autoimmune diseases."

Regarding cancer, regulatory T-cells prevent the system from attacking the growth, so studies are focused on reducing their quantity.

For self-attack disorders, experiments are testing increasing T-reg cells so the body is not being harmed. A similar approach could also be useful in minimizing the chances of transplanted organ failure.

Innovative Studies

Professor Shimon Sakaguchi, from Osaka University, conducted tests on rodents that had their immune gland extracted, leading to self-attack conditions.

The researcher demonstrated that injecting defense cells from other mice could stop the illness—implying there was a system for preventing defenders from harming the host.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, now at Sonoma Biotherapeutics in San Francisco, were studying an inherited immune disorder in rodents and people that led to the discovery of a genetic factor critical for the way T-regs function.

"Their pioneering research has revealed how the immune system is controlled by regulatory T cells, stopping it from accidentally targeting the body's own tissues," commented a prominent physiology specialist.

"The work is a remarkable illustration of how fundamental biological study can have broad implications for public health."